Inventor · disambiguated record
Dominique M. Missiakas
Also filed as: MISSIAKAS DOMINIQUE · MISSIAKAS DOMINIQUE M
18 granted patents·15 pending applications·111 citations·filing 2005–2024
94Inventor score
Top patents by PatentIndex Score
33 records- 0192US10464971B2Compositions and methods related to Protein A (SpA) VariantsUNIV CHICAGO·Filed 2017·Granted Nov 5, 2019·8 cites·9 claims
- 0292US8821894B2Compositions and methods related to protein A (SpA) variantsSCHNEEWIND OLAF·Filed 2011·Granted Sep 2, 2014·16 cites·11 claims
- 0391US9315554B2Compositions and methods related to protein A (SpA) variantsUNIV CHICAGO·Filed 2014·Granted Apr 19, 2016·11 cites·14 claims
- 0489US8945588B2Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptidesSCHNEEWIND OLAF·Filed 2012·Granted Feb 3, 2015·10 cites·21 claims
- 0589US8808699B2Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune responseSCHNEEWIND OLAF·Filed 2011·Granted Aug 19, 2014·15 cites·3 claims
- 0689US2025236649A1COMPOSITIONS AND METHODS RELATED TO PROTEIN A (SpA) VARIANTSUNIV CHICAGO·Filed 2024·Application pending·0 cites
- 0788US9095540B2Methods and compositions involving protective staphylococcal antigensSCHNEEWIND OLAF·Filed 2011·Granted Aug 4, 2015·6 cites·15 claims
- 0888US2024190927A1COMPOSITIONS AND METHODS RELATED TO PROTEIN A (SpA) VARIANTSUNIV CHICAGO·Filed 2024·Application pending·0 cites
- 0985US11059866B2Compositions and methods related to protein A (SpA) variantsUNIV CHICAGO·Filed 2019·Granted Jul 13, 2021·1 cites·15 claims
- 1085US9556281B2Compositions and methods related to antibodies to staphylococcal protein ASCHNEEWIND OLAF·Filed 2012·Granted Jan 31, 2017·4 cites·17 claims
- 1184US10857220B2Staphylococcal coagulase antigens and methods of their useUNIV CHICAGO·Filed 2018·Granted Dec 8, 2020·2 cites·20 claims
- 1283US10047149B2Compositions and methods related to antibodies to Staphylococcal protein AUNIV CHICAGO·Filed 2016·Granted Aug 14, 2018·4 cites·16 claims
- 1383US9212219B2Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune responseUNIV CHICAGO·Filed 2014·Granted Dec 15, 2015·5 cites·9 claims
- 1481US9968668B2Staphylococcal coagulase antigens and methods of their useUNIV CHICAGO·Filed 2013·Granted May 15, 2018·5 cites·21 claims
- 1581US9907850B2Compositions and methods related to protein A (SpA) antibodies as an enhancer of immune responseUNIV CHICAGO·Filed 2015·Granted Mar 6, 2018·3 cites·9 claims
- 1680US11214600B2Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus diseaseUNIV CHICAGO·Filed 2017·Granted Jan 4, 2022·2 cites·5 claims
- 1779US11939358B2Compositions and methods related to protein A (SpA) variantsUNIV CHICAGO·Filed 2021·Granted Mar 26, 2024·0 cites·18 claims
- 1879US9567379B2Compositions and methods related to protein A (SpA) variantsSCHNEEWIND OLAF·Filed 2010·Granted Feb 14, 2017·5 cites·14 claims
- 1978US8758765B2Compositions and methods related to Staphylococcal bacterium proteinsMISSIAKAS DOMINIQUE·Filed 2009·Granted Jun 24, 2014·10 cites·9 claims
- 2077US9701738B2Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus diseaseUNIV CHICAGO·Filed 2013·Granted Jul 11, 2017·4 cites·13 claims
- 2165US2021093706A1Staphylococcal coagulase antigens and methods of their useUNIV CHICAGO·Filed 2020·Application pending·0 cites
- 2261US2011262477A1Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA ProteinsUNIV CHICAGO·Filed 2009·Application pending·0 cites
- 2360US2022227819A1Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus diseaseUNIV CHICAGO·Filed 2021·Application pending·0 cites
- 2459US2016194363A1Compositions and Methods Related to Protein A (SpA) VariantsUNIV CHICAGO·Filed 2016·Application pending·0 cites
- 2551US2015246024A1Methods and compositions for inhibiting gram positive bacteriaUNIV CHICAGO·Filed 2013·Application pending·0 cites
- 2648US2016074497A1Staphylococcus live cell vaccinesUNIV CHICAGO·Filed 2014·Application pending·0 cites
- 2747US2009317421A1Compositions and methods related to staphylococcal bacterium proteinsMISSIAKAS DOMINIQUE·Filed 2007·Application pending·0 cites
- 2847US2022362368A1Staphylococcus peptides and methods of useJANSSEN VACCINES & PREVENTION BV·Filed 2020·Application pending·0 cites
- 2946US2014302084A1Immunogenic protein conjugates and method for making and using the sameSCHNEEWIND OLAF·Filed 2012·Application pending·0 cites
- 3046US2014271649A1Methods and compositions for inhibiting staphylococcus agglutination in bloodSCHNEEWIND OLAF·Filed 2012·Application pending·0 cites
- 3145US2017306004A1Compositions and methods related to antibodies that neutralize coagulase activity during staphylococcus aureus diseaseUNIV CHICAGO·Filed 2017·Application pending·0 cites
- 3238US2006275905A1Gram positive bacterial mutants and methods of generating and using such mutantsUNIV CHICAGO·Filed 2005·Application pending·0 cites
- 3338US2013236419A1Compositions and methods related to attenuated staphylococcal strainsSCHNEEWIND OLAF·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dominique M. Missiakas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →